Immune thrombocytopenia (ITP) is an autoimmune disorder defined by a significantly
reduced number of platelets in blood circulation. Due to low levels of platelets, ITP is …

Immune thrombocytopenia (ITP) is an autoimmune process resulting in increased
destruction and inadequate production of platelets that can result in bleeding, fatigue, and …

Immune thrombocytopenia (ITP) is isolated thrombocytopenia characterized by autoimmune-
mediated disruption of platelet without other etiologies. Treatments for chronic ITP consist of …

Introduction X-linked hypophosphataemia (XLH) is a rare, genetic renal phosphate-wasting
disease, resulting from excess fibroblast growth factor 23 (FGF23) activity, which has a …

Immune thrombocytopenia (ITP) is an autoimmune disease characterized by increased
platelet destruction along with reduced platelet production. All treatments attempt either to …

Platelets are small pieces of cytoplasm that have become detached from the cytoplasm of
mature megakaryocytes (MKs) in the bone marrow. Platelets modulate vascular system …

The fundamental treatment goal for patients with immune thrombocytopenia (ITP) is reduced
or ameliorated bleeding. Although various treatment options exist for the management of …

Over the last 2 years, different cases of immune thrombocytopenia (ITP) in patients affected
by SARS‐CoV2 have been reported. The management of SARS‐CoV2 in subjects with …

Objective Existing healthcare systems face finite resource allocation and budgetary
constraints, resulting in a substantial need for innovative solutions to enhance service …

Introduction The management of ITP has in recent years been transformed from reliance on
immunosuppressants and splenectomy to targeted therapy with thrombopoietin receptor …